tiprankstipranks
Praxis Precision Medicines, Inc. (PRAX)
NASDAQ:PRAX
US Market
PRAX
Praxis Precision Medicines
RESEARCH TOOLSreports
Want to see PRAX full AI Analyst Report?

Praxis Precision Medicines (PRAX) Stock Forecast & Price Target

991 Followers
See the Price Targets and Ratings of:

PRAX Analyst Ratings

Strong Buy
16Ratings
Strong Buy
14 Buy
1 Hold
1 Sell
Based on 16 analysts giving stock ratings to
Praxis
Precision Medicines
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

PRAX Stock 12 Month Forecast

Average Price Target

$643.38
▲(87.85% Upside)
Based on 16 Wall Street analysts offering 12 month price targets for Praxis Precision Medicines in the last 3 months. The average price target is $643.38 with a high forecast of $1,245.00 and a low forecast of $166.00. The average price target represents a 87.85% change from the last price of $342.50.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"37":"$37","1246":"$1,246","339.25":"$339.3","641.5":"$641.5","943.75":"$943.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1245,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.25K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":643.375,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$643.38</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":166,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$166.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[37,339.25,641.5,943.75,1246],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,324.2,395.03076923076924,465.86153846153843,536.6923076923076,607.5230769230768,678.353846153846,749.1846153846153,820.0153846153846,890.8461538461538,961.676923076923,1032.5076923076922,1103.3384615384614,1174.1692307692306,{"y":1245,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,324.2,348.75192307692305,373.30384615384617,397.8557692307692,422.4076923076923,446.9596153846154,471.51153846153846,496.0634615384615,520.6153846153846,545.1673076923078,569.7192307692308,594.2711538461538,618.823076923077,{"y":643.375,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,324.2,312.03076923076924,299.86153846153843,287.6923076923077,275.5230769230769,263.3538461538461,251.18461538461537,239.01538461538462,226.84615384615384,214.67692307692306,202.5076923076923,190.33846153846153,178.16923076923075,{"y":166,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":38.06,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":39.82,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":43.17,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.09,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.94,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.02,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":198.76,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":184.56,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 55,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":294.74,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 51,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":309.11,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 51,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.59,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":319.28,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":324.2,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$1,245Average Price Target$643.38Lowest Price Target$166.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on PRAX
Joon Lee
Truist Financial
Truist Financial
$700→$715
Buy
108.76%
Upside
Initiated
05/13/26
Praxis Precision assumed with a Buy at TruistPraxis Precision assumed with a Buy at Truist
LifeSci Capital Analyst forecast on PRAX
Francois Brisebois
LifeSci Capital
LifeSci Capital
$795
Buy
132.12%
Upside
Assigned
05/09/26
Analysts Conflicted on These Healthcare Names: BioNTech SE (NASDAQ: BNTX), Repligen (NASDAQ: RGEN) and Praxis Precision Medicines (NASDAQ: PRAX)
H.C. Wainwright Analyst forecast on PRAX
Douglas Tsao
H.C. Wainwright
H.C. Wainwright
$1,245
Buy
263.50%
Upside
Reiterated
05/08/26
H.C. Wainwright Reaffirms Their Buy Rating on Praxis Precision Medicines (PRAX)
Wedbush Analyst forecast on PRAX
Laura Chico
Wedbush
Wedbush
$130→$166
Sell
-51.53%
Downside
Reiterated
05/08/26
Wedbush Remains a Sell on Praxis Precision Medicines (PRAX)
Deutsche Bank Analyst forecast on PRAX
David Hoang
Deutsche Bank
Deutsche Bank
$444→$420
Buy
22.63%
Upside
Reiterated
05/08/26
Praxis Precision price target lowered to $420 from $444 at Deutsche BankPraxis Precision price target lowered to $420 from $444 at Deutsche Bank
BTIG Analyst forecast on PRAX
Kambiz Yazdi
BTIG
BTIG
$843
Buy
146.13%
Upside
Reiterated
05/08/26
Praxis Precision Medicines (PRAX) Gets a Buy from BTIG
TD Cowen Analyst forecast on PRAX
Ritu Baral
TD Cowen
TD Cowen
$554
Buy
61.75%
Upside
Reiterated
05/07/26
Praxis Therapeutics: Advancing Late-Stage Neurology Pipeline and De-Risked Ulixacaltamide NDA Support Unchanged $554 Buy Target
Guggenheim Analyst forecast on PRAX
Yatin Suneja
Guggenheim
Guggenheim
$800
Buy
133.58%
Upside
Reiterated
05/07/26
Guggenheim Sticks to Its Buy Rating for Praxis Precision Medicines (PRAX)
Needham Analyst forecast on PRAX
Ami Fadia
Needham
Needham
$510→$537
Buy
56.79%
Upside
Reiterated
05/07/26
Analysts Are Bullish on These Healthcare Stocks: Praxis Precision Medicines (PRAX), NewAmsterdam Pharma Company (NAMS)
JonesTrading Analyst forecast on PRAX
Justin Walsh
JonesTrading
JonesTrading
$441
Buy
28.76%
Upside
Reiterated
05/07/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wells Fargo Analyst forecast on PRAX
Benjamin Burnett
Wells Fargo
Wells Fargo
$305
Hold
-10.95%
Downside
Reiterated
04/23/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Roche Holding (Other OTC: RHHBY), Praxis Precision Medicines (NASDAQ: PRAX) and SAB Biotherapeutics (NASDAQ: SABS)
Piper Sandler Analyst forecast on PRAX
Yasmeen Rahimi
Piper Sandler
Piper Sandler
$1,200
Buy
250.36%
Upside
Reiterated
04/21/26
Analysts Offer Insights on Healthcare Companies: TransMedics Group (NASDAQ: TMDX), Intuitive Surgical (NASDAQ: ISRG) and Praxis Precision Medicines (NASDAQ: PRAX)
Raymond James Analyst forecast on PRAX
Tiago Fauth
Raymond James
Raymond James
$815
Buy
137.96%
Upside
Initiated
04/08/26
Praxis Precision initiated with a Strong Buy at Raymond JamesPraxis Precision initiated with a Strong Buy at Raymond James
Wolfe Research Analyst forecast on PRAX
Rudy Li
Wolfe Research
Wolfe Research
$500
Buy
45.99%
Upside
Reiterated
04/06/26
Praxis: EMBRAVE Data Validate Elsunersen and De‑Risk Pipeline, Supporting Buy Rating on Favorable Risk‑Reward
Jefferies Analyst forecast on PRAX
Andrew Tsai
Jefferies
Jefferies
$525
Buy
53.28%
Upside
Reiterated
03/31/26
Jefferies Reaffirms Their Buy Rating on Praxis Precision Medicines (PRAX)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Truist Financial Analyst forecast on PRAX
Joon Lee
Truist Financial
Truist Financial
$700→$715
Buy
108.76%
Upside
Initiated
05/13/26
Praxis Precision assumed with a Buy at TruistPraxis Precision assumed with a Buy at Truist
LifeSci Capital Analyst forecast on PRAX
Francois Brisebois
LifeSci Capital
LifeSci Capital
$795
Buy
132.12%
Upside
Assigned
05/09/26
Analysts Conflicted on These Healthcare Names: BioNTech SE (NASDAQ: BNTX), Repligen (NASDAQ: RGEN) and Praxis Precision Medicines (NASDAQ: PRAX)
H.C. Wainwright Analyst forecast on PRAX
Douglas Tsao
H.C. Wainwright
H.C. Wainwright
$1,245
Buy
263.50%
Upside
Reiterated
05/08/26
H.C. Wainwright Reaffirms Their Buy Rating on Praxis Precision Medicines (PRAX)
Wedbush Analyst forecast on PRAX
Laura Chico
Wedbush
Wedbush
$130→$166
Sell
-51.53%
Downside
Reiterated
05/08/26
Wedbush Remains a Sell on Praxis Precision Medicines (PRAX)
Deutsche Bank Analyst forecast on PRAX
David Hoang
Deutsche Bank
Deutsche Bank
$444→$420
Buy
22.63%
Upside
Reiterated
05/08/26
Praxis Precision price target lowered to $420 from $444 at Deutsche BankPraxis Precision price target lowered to $420 from $444 at Deutsche Bank
BTIG Analyst forecast on PRAX
Kambiz Yazdi
BTIG
BTIG
$843
Buy
146.13%
Upside
Reiterated
05/08/26
Praxis Precision Medicines (PRAX) Gets a Buy from BTIG
TD Cowen Analyst forecast on PRAX
Ritu Baral
TD Cowen
TD Cowen
$554
Buy
61.75%
Upside
Reiterated
05/07/26
Praxis Therapeutics: Advancing Late-Stage Neurology Pipeline and De-Risked Ulixacaltamide NDA Support Unchanged $554 Buy Target
Guggenheim Analyst forecast on PRAX
Yatin Suneja
Guggenheim
Guggenheim
$800
Buy
133.58%
Upside
Reiterated
05/07/26
Guggenheim Sticks to Its Buy Rating for Praxis Precision Medicines (PRAX)
Needham Analyst forecast on PRAX
Ami Fadia
Needham
Needham
$510→$537
Buy
56.79%
Upside
Reiterated
05/07/26
Analysts Are Bullish on These Healthcare Stocks: Praxis Precision Medicines (PRAX), NewAmsterdam Pharma Company (NAMS)
JonesTrading Analyst forecast on PRAX
Justin Walsh
JonesTrading
JonesTrading
$441
Buy
28.76%
Upside
Reiterated
05/07/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Wells Fargo Analyst forecast on PRAX
Benjamin Burnett
Wells Fargo
Wells Fargo
$305
Hold
-10.95%
Downside
Reiterated
04/23/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Roche Holding (Other OTC: RHHBY), Praxis Precision Medicines (NASDAQ: PRAX) and SAB Biotherapeutics (NASDAQ: SABS)
Piper Sandler Analyst forecast on PRAX
Yasmeen Rahimi
Piper Sandler
Piper Sandler
$1,200
Buy
250.36%
Upside
Reiterated
04/21/26
Analysts Offer Insights on Healthcare Companies: TransMedics Group (NASDAQ: TMDX), Intuitive Surgical (NASDAQ: ISRG) and Praxis Precision Medicines (NASDAQ: PRAX)
Raymond James Analyst forecast on PRAX
Tiago Fauth
Raymond James
Raymond James
$815
Buy
137.96%
Upside
Initiated
04/08/26
Praxis Precision initiated with a Strong Buy at Raymond JamesPraxis Precision initiated with a Strong Buy at Raymond James
Wolfe Research Analyst forecast on PRAX
Rudy Li
Wolfe Research
Wolfe Research
$500
Buy
45.99%
Upside
Reiterated
04/06/26
Praxis: EMBRAVE Data Validate Elsunersen and De‑Risk Pipeline, Supporting Buy Rating on Favorable Risk‑Reward
Jefferies Analyst forecast on PRAX
Andrew Tsai
Jefferies
Jefferies
$525
Buy
53.28%
Upside
Reiterated
03/31/26
Jefferies Reaffirms Their Buy Rating on Praxis Precision Medicines (PRAX)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Praxis Precision Medicines

3 Months
Francois BriseboisLifeSci Capital
Success Rate
11/12 ratings generated profit
92%
Average Return
+78.13%
Copying Francois Brisebois's trades and holding each position for 3 Months would result in 91.67% of your transactions generating a profit, with an average return of +78.13% per trade.
1 Year
Ami FadiaNeedham
Success Rate
15/18 ratings generated profit
83%
Average Return
+271.77%
Copying Ami Fadia's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +271.77% per trade.
2 Years
Douglas TsaoH.C. Wainwright
Success Rate
27/27 ratings generated profit
100%
Average Return
+396.74%
Copying Douglas Tsao's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +396.74% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

PRAX Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
27
30
23
28
24
Buy
24
21
8
8
6
Hold
0
2
2
4
2
Sell
0
0
0
0
1
Strong Sell
2
3
2
1
0
total
53
56
35
41
33
In the current month, PRAX has received 30 Buy Ratings, 2 Hold Ratings, and 1 Sell Ratings. PRAX average Analyst price target in the past 3 months is 643.38.
Each month's total comprises the sum of three months' worth of ratings.

PRAX Financial Forecast

PRAX Earnings Forecast

Next quarter’s earnings estimate for PRAX is -$3.67 with a range of -$5.09 to -$3.04. The previous quarter’s EPS was -$3.20. PRAX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year PRAX has Performed in-line its overall industry.
Next quarter’s earnings estimate for PRAX is -$3.67 with a range of -$5.09 to -$3.04. The previous quarter’s EPS was -$3.20. PRAX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year PRAX has Performed in-line its overall industry.

PRAX Sales Forecast

Next quarter’s sales forecast for PRAX is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. PRAX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year PRAX has Performed in-line its overall industry.
Next quarter’s sales forecast for PRAX is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. PRAX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year PRAX has Performed in-line its overall industry.

PRAX Stock Forecast FAQ

What is PRAX’s average 12-month price target, according to analysts?
Based on analyst ratings, Praxis Precision Medicines, Inc.’s 12-month average price target is 643.38.
    What is PRAX’s upside potential, based on the analysts’ average price target?
    Praxis Precision Medicines, Inc. has 87.85% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is PRAX a Buy, Sell or Hold?
          Praxis Precision Medicines, Inc. has a consensus rating of Strong Buy which is based on 14 buy ratings, 1 hold ratings and 1 sell ratings.
            What is Praxis Precision Medicines, Inc.’s price target?
            The average price target for Praxis Precision Medicines, Inc. is 643.38. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $1,245.00 ,the lowest forecast is $166.00. The average price target represents 87.85% Increase from the current price of $342.5.
              What do analysts say about Praxis Precision Medicines, Inc.?
              Praxis Precision Medicines, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.
                How can I buy shares of PRAX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.